CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia. [electronic resource]
Producer: 20180305Description: 29679-29698 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Disease Models, Animal
- Drug Resistance, Neoplasm -- drug effects
- Female
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Imatinib Mesylate -- pharmacology
- JNK Mitogen-Activated Protein Kinases -- metabolism
- K562 Cells
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Mice
- Naphthoquinones -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- STAT5 Transcription Factor -- metabolism
- Signal Transduction
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.